{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T22:36:08Z","timestamp":1786746968320,"version":"build-2736575974"},"reference-count":170,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,8,28]],"date-time":"2024-08-28T00:00:00Z","timestamp":1724803200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell Dev. Biol."],"abstract":"<jats:p>Cervical cancer (CC) is the most common cancer in women and poses a serious threat to health. Despite familiarity with the factors affecting its etiology, initiation, progression, treatment strategies, and even resistance to therapy, it is considered a significant problem for women. However, several factors have greatly affected the previous aspects of CC progression and treatment in recent decades. miRNAs are short non-coding RNA sequences that regulate gene expression by inhibiting translation of the target mRNA. miRNAs play a crucial role in CC pathogenesis by promoting cancer stem cell (CSC) proliferation, postponing apoptosis, continuing the cell cycle, and promoting invasion, angiogenesis, and metastasis. Similarly, miRNAs influence important CC-related molecular pathways, such as the PI3K\/AKT\/mTOR signaling pathway, Wnt\/\u03b2-catenin system, JAK\/STAT signaling pathway, and MAPK signaling pathway. Moreover, miRNAs affect the response of CC patients to chemotherapy and radiotherapy. Consequently, this review aims to provide an acquainted summary of onco miRNAs and tumor suppressor (TS) miRNAs and their potential role in CC pathogenesis and therapy responses by focusing on the molecular pathways that drive them.<\/jats:p>","DOI":"10.3389\/fcell.2024.1397945","type":"journal-article","created":{"date-parts":[[2024,8,28]],"date-time":"2024-08-28T04:33:55Z","timestamp":1724819635000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":25,"title":["Understanding the role of miRNAs in cervical cancer pathogenesis and therapeutic responses"],"prefix":"10.3389","volume":"12","author":[{"given":"Prashant","family":"Chauhan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sreepoorna","family":"Pramodh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arif","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deena","family":"Elsori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sorabh","family":"Lakhanpal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Alsaweed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danish","family":"Iqbal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pratibha","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayoub","family":"Al Othaim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fahad","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,8,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"102159","DOI":"10.1016\/j.jogoh.2021.102159","article-title":"Role of miRNAs in cervical cancer: a comprehensive novel approach from pathogenesis to therapy","volume":"50","author":"Abbas","year":"2021","journal-title":"J. Gynecol. Obstetrics Hum. Reproduction"},{"key":"B2","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1515\/bmc-2014-0012","article-title":"Update on non-canonical microRNAs","volume":"5","author":"Abdelfattah","year":"2014","journal-title":"Biomol. concepts"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jbior.2014.09.013","article-title":"MicroRNA and cancer\u2013a brief overview","volume":"57","author":"Acunzo","year":"2015","journal-title":"Adv. Biol. Regul."},{"key":"B4","doi-asserted-by":"publisher","first-page":"10323","DOI":"10.1038\/s41598-021-89388-w","article-title":"Urine miRNA signature as a potential non-invasive diagnostic and prognostic biomarker in cervical cancer","volume":"11","author":"Aftab","year":"2021","journal-title":"Sci. Rep."},{"key":"B5","doi-asserted-by":"publisher","first-page":"119499","DOI":"10.1016\/j.lfs.2021.119499","article-title":"Interplay between MAPK\/ERK signaling pathway and MicroRNAs: a crucial mechanism regulating cancer cell metabolism and tumor progression","volume":"278","author":"Asl","year":"2021","journal-title":"Life Sci."},{"key":"B150","first-page":"16885","article-title":"Tumor-derived exosomes: Implication in angiogenesis and antiangiogenesis cancer therapy","volume-title":"J. Cell. Physiol.","author":"Aslan","year":"2019"},{"key":"B6","doi-asserted-by":"publisher","first-page":"4163","DOI":"10.1002\/jcb.26118","article-title":"The potential value of the PI3K\/Akt\/mTOR signaling pathway for assessing prognosis in cervical cancer and as a target for therapy","volume":"118","author":"Bahrami","year":"2017","journal-title":"J. Cell. Biochem."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2014\/178075","article-title":"MicroRNA in cervical cancer: OncomiRs and tumor suppressor miRs in diagnosis and treatment","volume":"2","author":"Banno","year":"2014","journal-title":"Sci. World J."},{"key":"B8","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1186\/1476-4598-12-155","article-title":"A TrkB\u2013STAT3\u2013miR-204-5p regulatory circuitry controls proliferation and invasion of endometrial carcinoma cells","volume":"12","author":"Bao","year":"2013","journal-title":"Mol. cancer"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.3892\/or.2018.6936","article-title":"miR-107-5p promotes tumor proliferation and invasion by targeting estrogen receptor-\u03b1 in endometrial carcinoma","volume":"41","author":"Bao","year":"2019","journal-title":"Oncol. Rep."},{"key":"B10","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s10555-017-9724-7","article-title":"miR-155 in cancer drug resistance and as target for miRNA-based therapeutics","volume":"37","author":"Bayraktar","year":"2018","journal-title":"Cancer Metastasis Rev."},{"key":"B11","doi-asserted-by":"publisher","first-page":"113345","DOI":"10.1016\/j.biopha.2022.113345","article-title":"Cellular landscaping of cisplatin resistance in cervical cancer","volume":"153","author":"Bhattacharjee","year":"2022","journal-title":"Biomed. and Pharmacother."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/15476286.2023.2288741","article-title":"Recent progress in miRNA biogenesis and decay","volume":"21","author":"Bofill-De Ros","year":"2024","journal-title":"RNA Biol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"668","DOI":"10.3390\/cells10030668","article-title":"A systematic review of microRNAs involved in cervical cancer progression","volume":"10","author":"Causin","year":"2021","journal-title":"Cells"},{"key":"B14","doi-asserted-by":"publisher","first-page":"109064","DOI":"10.1016\/j.biopha.2019.109064","article-title":"circMTO1 promotes tumorigenesis and chemoresistance of cervical cancer via regulating miR-6893","volume":"117","author":"Chen","year":"2019","journal-title":"Biomed. and Pharmacother."},{"key":"B15","doi-asserted-by":"publisher","first-page":"544","DOI":"10.3389\/fphar.2020.00544","article-title":"Identification of prognostic miRNA signature and lymph node metastasis-related key genes in cervical cancer","volume":"11","author":"Chen","year":"","journal-title":"Front. Pharmacol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.biopha.2016.04.023","article-title":"MicroRNA-744 inhibited cervical cancer growth and progression through apoptosis induction by regulating Bcl-2","volume":"81","author":"Chen","year":"2016","journal-title":"Biomed. and Pharmacother."},{"key":"B17","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s10495-019-01588-y","article-title":"microRNA-499a promotes the progression and chemoresistance of cervical cancer cells by targeting SOX6","volume":"25","author":"Chen","year":"","journal-title":"Apoptosis"},{"key":"B18","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/b978-0-443-13212-4.00026-x","article-title":"Regulation of cancer stemness, cell signaling, reactive oxygen species, and microRNAs in cancer stem cells","author":"Chengizkhan","year":"2024","journal-title":"Cancer Stem Cells Signal. Pathw."},{"key":"B19","doi-asserted-by":"publisher","first-page":"6080","DOI":"10.3390\/molecules19056080","article-title":"Issues and prospects of microRNA-based biomarkers in blood and other body fluids","volume":"19","author":"Chevillet","year":"2014","journal-title":"Molecules"},{"key":"B20","doi-asserted-by":"publisher","first-page":"7126","DOI":"10.3390\/ijms23137126","article-title":"The dysregulation of MicroRNAs in the development of cervical pre-cancer\u2014an update","volume":"23","author":"Choi","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"B21","doi-asserted-by":"publisher","first-page":"337","DOI":"10.3389\/fgene.2014.00337","article-title":"A non-canonical landscape of the microRNA system","volume":"5","author":"Cipolla","year":"2014","journal-title":"Front. Genet."},{"key":"B22","doi-asserted-by":"publisher","first-page":"220","DOI":"10.3390\/cells9010220","article-title":"miRNAs as influencers of cell\u2013cell communication in tumor microenvironment","volume":"9","author":"Conti","year":"2020","journal-title":"Cells"},{"key":"B23","doi-asserted-by":"publisher","first-page":"e0267108","DOI":"10.1371\/journal.pone.0267108","article-title":"The clinical value of miRNA-21 in cervical cancer: a comprehensive investigation based on microarray datasets","volume":"17","author":"Deng","year":"2022","journal-title":"PLoS One"},{"key":"B24","doi-asserted-by":"publisher","first-page":"5167","DOI":"10.3390\/ijms23095167","article-title":"Cancer stem cells and their possible implications in cervical cancer: a short review","volume":"23","author":"Di Fiore","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"B25","doi-asserted-by":"publisher","first-page":"154386","DOI":"10.1016\/j.prp.2023.154386","article-title":"miRNAs role in cervical cancer pathogenesis and targeted therapy: signaling pathways interplay","volume":"244","author":"Doghish","year":"2023","journal-title":"Pathology-Research Pract."},{"key":"B26","doi-asserted-by":"publisher","first-page":"3289","DOI":"10.3892\/mmr.2014.2622","article-title":"Restoration of microRNA-218 increases cellular chemosensitivity to cervical cancer by inhibiting cell-cycle progression","volume":"10","author":"Dong","year":"2014","journal-title":"Mol. Med. Rep."},{"key":"B27","doi-asserted-by":"publisher","first-page":"2713","DOI":"10.3892\/mmr.2017.6340","article-title":"miR-21 inhibitor suppresses cell proliferation and colony formation through regulating the PTEN\/AKT pathway and improves paclitaxel sensitivity in cervical cancer cells","volume":"15","author":"Du","year":"2017","journal-title":"Mol. Med. Rep."},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1002\/9780470015902.a0025214","article-title":"Role of the JAK-STAT signalling pathway in cancer","author":"Dutta","year":"2013","journal-title":"eLS"},{"key":"B29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-0716-1170-8_1","article-title":"Regulation of microRNAs","volume-title":"miRNomics: MicroRNA biology and computational analysis","author":"Ergin","year":"2022"},{"key":"B30","doi-asserted-by":"publisher","first-page":"414","DOI":"10.3892\/etm.2021.9858","article-title":"miR-130a-3p promotes cell proliferation and invasion by targeting estrogen receptor \u03b1 and androgen receptor in cervical cancer","volume":"21","author":"Fan","year":"2021","journal-title":"Exp. Ther. Med."},{"key":"B31","doi-asserted-by":"publisher","first-page":"25266","DOI":"10.18632\/oncotarget.4457","article-title":"MiR-125a suppresses tumor growth, invasion and metastasis in cervical cancer by targeting STAT3","volume":"6","author":"Fan","year":"2015","journal-title":"Oncotarget"},{"key":"B32","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1080\/15384101.2017.1395533","article-title":"SOX9\/miR-130a\/CTR1 axis modulates DDP-resistance of cervical cancer cell","volume":"17","author":"Feng","year":"2018","journal-title":"Cell Cycle"},{"key":"B33","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s10555-017-9715-8","article-title":"Non-coding RNAs, epigenetics, and cancer: tying it all together","volume":"37","author":"Ferreira","year":"2018","journal-title":"Cancer Metastasis Rev."},{"key":"B34","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/s12957-020-01881-0","article-title":"MiR-125 inhibited cervical cancer progression by regulating VEGF and PI3K\/AKT signaling pathway","volume":"18","author":"Fu","year":"2020","journal-title":"World J. Surg. Oncol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1517\/14728222.2011.550878","article-title":"MicroRNAs as new therapeutic targets and tools in cancer","volume":"15","author":"Gandellini","year":"2011","journal-title":"Expert Opin. Ther. targets"},{"key":"B36","doi-asserted-by":"publisher","first-page":"7080","DOI":"10.1002\/jcb.27029","article-title":"MicroRNA expression in cervical cancer: novel diagnostic and prognostic biomarkers","volume":"119","author":"Gao","year":"2018","journal-title":"J. Cell. Biochem."},{"key":"B37","doi-asserted-by":"publisher","first-page":"5328","DOI":"10.2174\/1381612820666140128211346","article-title":"MicroRNAs as anti-cancer therapy","volume":"20","author":"Garofalo","year":"2014","journal-title":"Curr. Pharm. Des."},{"key":"B38","doi-asserted-by":"publisher","first-page":"e0268480","DOI":"10.1371\/journal.pone.0268480","article-title":"Disease progression role as well as the diagnostic and prognostic value of microRNA-21 in patients with cervical cancer: a systematic review and meta-analysis","volume":"17","author":"Gebrie","year":"2022","journal-title":"Plos one"},{"key":"B39","first-page":"1350","article-title":"Resistance to cancer chemotherapeutic drugs is determined by pivotal microRNA regulators","volume":"7","author":"Geretto","year":"2017","journal-title":"Am. J. cancer Res."},{"key":"B40","doi-asserted-by":"publisher","first-page":"241","DOI":"10.2174\/1568009614666140305104845","article-title":"Novel insights into the role of microRNA in lung cancer resistance to treatment and targeted therapy","volume":"14","author":"Gong","year":"2014","journal-title":"Curr. cancer drug targets"},{"key":"B41","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3892\/or.2015.4369","article-title":"MicroRNAs are involved in cervical cancer development, progression, clinical outcome and improvement treatment response (Review)","volume":"35","author":"Gonz\u00e1lez-Quintana","year":"2016","journal-title":"Oncol. Rep."},{"key":"B42","doi-asserted-by":"publisher","first-page":"407","DOI":"10.3390\/ijms18020407","article-title":"Use of mature miRNA strand selection in miRNAs families in cervical cancer development","volume":"18","author":"Granados-L\u00f3pez","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"B43","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1038\/ncb1722","article-title":"The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1","volume":"10","author":"Gregory","year":"2008","journal-title":"Nat. Cell Biol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"2297","DOI":"10.3390\/cells9102297","article-title":"Role of the JAK\/STAT pathway in cervical cancer: its relationship with HPV E6\/E7 oncoproteins","volume":"9","author":"Guti\u00e9rrez-Hoya","year":"2020","journal-title":"Cells"},{"key":"B45","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s43141-023-00469-x","article-title":"Systematic approach to identify therapeutic targets and functional pathways for the cervical cancer","volume":"21","author":"Hasan","year":"2023","journal-title":"J. Genet. Eng. Biotechnol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"4626","DOI":"10.1093\/nar\/gks026","article-title":"Biogenesis of mammalian microRNAs by a non-canonical processing pathway","volume":"40","author":"Havens","year":"2012","journal-title":"Nucleic acids Res."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1002\/ijc.29618","article-title":"A systematic study on dysregulated micro RNA s in cervical cancer development","volume":"138","author":"He","year":"2016","journal-title":"Int. J. cancer"},{"key":"B48","doi-asserted-by":"publisher","first-page":"4553","DOI":"10.1007\/s11033-020-05494-4","article-title":"Role of microRNAs in epidermal growth factor receptor signaling pathway in cervical cancer","volume":"47","author":"Hemmat","year":"2020","journal-title":"Mol. Biol. Rep."},{"key":"B68","first-page":"10369","article-title":"Dicer-independent processing of small RNA duplexes: mechanistic insights and applications","volume-title":"Nucleic. Acids Res.","author":"Herrera-Carrillo","year":"2017"},{"key":"B49","doi-asserted-by":"publisher","first-page":"6339","DOI":"10.3390\/cancers13246339","article-title":"New trends in the detection of gynecological precancerous lesions and early-stage cancers","volume":"13","author":"Holcakova","year":"2021","journal-title":"Cancers"},{"key":"B50","doi-asserted-by":"publisher","first-page":"905","DOI":"10.2147\/OTT.S282790","article-title":"Baicalein represses cervical cancer cell growth, cell cycle progression and promotes apoptosis via blocking akt\/mtor pathway by the regulation of circhiat1\/mir-19a-3p axis","volume":"9","author":"Hu","year":"2021","journal-title":"OncoTargets Ther."},{"key":"B51","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1002\/kjm2.12181","article-title":"miR\u2010636 represses cell survival by targeting CDK6\/Bcl\u20102 in cervical cancer","volume":"36","author":"Hu","year":"2020","journal-title":"Kaohsiung J. Med. Sci."},{"key":"B52","doi-asserted-by":"publisher","first-page":"5342","DOI":"10.26355\/eurrev_201712_13919","article-title":"MiRNA-338-3p regulates cervical cancer cells proliferation by targeting MACC1 through MAPK signaling pathway","volume":"21","author":"Hua","year":"2017","journal-title":"Eur. Rev. Med. and Pharmacol. Sci."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1016\/j.biopha.2017.07.150","article-title":"MicroRNA-374c-5p regulates the invasion and migration of cervical cancer by acting on the Foxc1\/snail pathway","volume":"94","author":"Huang","year":"2017","journal-title":"Biomed. and Pharmacother."},{"key":"B54","doi-asserted-by":"publisher","first-page":"e0162378","DOI":"10.1371\/journal.pone.0162378","article-title":"Over-expressed miR-224 promotes the progression of cervical cancer via targeting RASSF8","volume":"11","author":"Huang","year":"2016","journal-title":"PLoS One"},{"key":"B55","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1002\/emmm.201100209","article-title":"MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review","volume":"4","author":"Iorio","year":"2012","journal-title":"EMBO Mol. Med."},{"key":"B56","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.molcel.2021.11.026","article-title":"Life of RISC: formation, action, and degradation of RNA-induced silencing complex","volume":"82","author":"Iwakawa","year":"2022","journal-title":"Mol. Cell"},{"key":"B57","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.semcancer.2017.02.004","article-title":"Role of miRNAs in human cancer metastasis: implications for therapeutic intervention","volume":"44","author":"Jafri","year":"2017","journal-title":"InSeminars cancer Biol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"375","DOI":"10.2174\/1566523217666170102105119","article-title":"miR-21, an oncogenic target miRNA for cancer therapy: molecular mechanisms and recent advancements in chemo and radio-resistance","volume":"16","author":"Javanmardi","year":"2016","journal-title":"Curr. gene Ther."},{"key":"B59","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.3892\/or.2015.4099","article-title":"miR-130a acts as a potential diagnostic biomarker and promotes gastric cancer migration, invasion and proliferation by targeting RUNX3","volume":"34","author":"Jiang","year":"2015","journal-title":"Oncol. Rep."},{"key":"B60","doi-asserted-by":"publisher","first-page":"610","DOI":"10.3390\/diagnostics13040610","article-title":"Prevention strategies and early diagnosis of cervical cancer: current state and prospects","volume":"13","author":"Kakotkin","year":"2023","journal-title":"Diagnostics"},{"key":"B61","doi-asserted-by":"publisher","first-page":"5414","DOI":"10.3390\/cancers14215414","article-title":"The role of miR-155 in antitumor immunity","volume":"14","author":"Kalkusova","year":"2022","journal-title":"Cancers"},{"key":"B62","doi-asserted-by":"publisher","first-page":"101109","DOI":"10.1016\/j.genrep.2021.101109","article-title":"Potential of miRNAs in cervical cancer chemoresistance","volume":"23","author":"Karimi","year":"2021","journal-title":"Gene Rep."},{"key":"B63","doi-asserted-by":"publisher","first-page":"62","DOI":"10.2174\/18756301mtawanzks4","article-title":"Cancer immunotherapy: an effective tool in cancer control and treatment","volume":"16","author":"Kaur","year":"2020","journal-title":"Curr. Cancer Ther. Rev."},{"key":"B64","doi-asserted-by":"publisher","first-page":"3019","DOI":"10.1038\/onc.2012.323","article-title":"MiR-181a confers resistance of cervical cancer to radiation therapy through targeting the pro-apoptotic PRKCD gene","volume":"32","author":"Ke","year":"2013","journal-title":"Oncogene"},{"key":"B65","doi-asserted-by":"publisher","first-page":"840","DOI":"10.3390\/cells8080840","article-title":"Role of miRNA-regulated cancer stem cells in the pathogenesis of human malignancies","volume":"8","author":"Khan","year":"2019","journal-title":"Cells"},{"key":"B66","doi-asserted-by":"publisher","first-page":"965231","DOI":"10.3389\/fonc.2022.965231","article-title":"The role of miR-200 family in the regulation of hallmarks of cancer","volume":"12","author":"Klicka","year":"2022","journal-title":"Front. Oncol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"169","DOI":"10.2174\/138920209788185289","article-title":"Estrogen regulation of microRNA expression","volume":"10","author":"Klinge","year":"2009","journal-title":"Curr. genomics"},{"key":"B69","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.3892\/or.2020.7703","article-title":"MicroRNAs target the Wnt\/\u03b2\u2011catenin signaling pathway to regulate epithelial\u2011mesenchymal transition in cancer (Review)","volume":"44","author":"Lei","year":"2020","journal-title":"Oncol. Rep."},{"key":"B70","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1111\/IGC.0b013e3181d63170","article-title":"Reduced miR-34a expression in normal cervical tissues and cervical lesions with high-risk human papillomavirus infection","volume":"20","author":"Li","year":"2010","journal-title":"Int. J. Gynecol. Cancer"},{"key":"B71","doi-asserted-by":"publisher","first-page":"2166","DOI":"10.1016\/j.ejca.2011.04.037","article-title":"Reduced miR-100 expression in cervical cancer and precursors and its carcinogenic effect through targeting PLK1 protein","volume":"47","author":"Li","year":"","journal-title":"Eur. J. Cancer"},{"key":"B72","doi-asserted-by":"publisher","first-page":"81","DOI":"10.14715\/cmb\/2022.68.2.12","article-title":"miR-218 affects the invasion and metastasis of cervical cancer cells by inhibiting the expression of SFMBT1 and DCUNIDI","volume":"68","author":"Li","year":"2022","journal-title":"Cell. Mol. Biol."},{"key":"B73","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s12867-015-0052-6","article-title":"microRNA-150 promotes cervical cancer cell growth and survival by targeting FOXO4","volume":"16","author":"Li","year":"2015","journal-title":"BMC Mol. Biol."},{"key":"B74","doi-asserted-by":"publisher","first-page":"16053","DOI":"10.3390\/ijms131216053","article-title":"MiR-218 impairs tumor growth and increases chemo-sensitivity to cisplatin in cervical cancer","volume":"13","author":"Li","year":"2012","journal-title":"Int. J. Mol. Sci."},{"key":"B75","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.ygyno.2010.09.009","article-title":"MicroRNA miR-886-5p inhibits apoptosis by down-regulating Bax expression in human cervical carcinoma cells","volume":"120","author":"Li","year":"","journal-title":"Gynecol. Oncol."},{"key":"B76","doi-asserted-by":"publisher","first-page":"BSR20171563","DOI":"10.1042\/BSR20171563","article-title":"HOTAIR contributes to cell proliferation and metastasis of cervical cancer via targetting miR-23b\/MAPK1 axis","volume":"38","author":"Li","year":"2018","journal-title":"Biosci. Rep."},{"key":"B77","doi-asserted-by":"publisher","first-page":"2897","DOI":"10.3892\/or.2019.7046","article-title":"miR-146a regulates the function of Th17 cell differentiation to modulate cervical cancer cell growth and apoptosis through NF-\u03baB signaling by targeting TRAF6","volume":"41","author":"Li","year":"","journal-title":"Oncol. Rep."},{"key":"B78","doi-asserted-by":"publisher","first-page":"2743","DOI":"10.3892\/or.2017.5555","article-title":"MicroRNA-329-3p targets MAPK1 to suppress cell proliferation, migration and invasion in cervical cancer","volume":"37","author":"Li","year":"2017","journal-title":"Oncol. Rep."},{"key":"B79","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000006919","volume-title":"Retracted: microRNA\u201099b suppresses human cervical cancer cell activity by inhibiting the PI3K\/AKT\/mTOR signaling pathway","author":"Li","year":""},{"key":"B80","doi-asserted-by":"publisher","first-page":"195","DOI":"10.3892\/or.2023.8632","article-title":"[Retracted] miR-187 inhibits the growth of cervical cancer cells by targeting FGF9","volume":"50","author":"Liang","year":"2023","journal-title":"Oncol. Rep."},{"key":"B81","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1080\/15384047.2018.1423921","article-title":"Long non-coding RNA HOTAIR promotes cervical cancer progression through regulating BCL2 via targeting miR-143-3p","volume":"19","author":"Liu","year":"2018","journal-title":"Cancer Biol. and Ther."},{"key":"B82","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1016\/j.febslet.2013.05.054","article-title":"MicroRNA-7 downregulates XIAP expression to suppress cell growth and promote apoptosis in cervical cancer cells","volume":"587","author":"Liu","year":"2013","journal-title":"FEBS Lett."},{"key":"B83","doi-asserted-by":"publisher","first-page":"570","DOI":"10.3892\/ijo.2019.4847","article-title":"Current strategies against persistent human papillomavirus infection (Review)","volume":"55","author":"Liu","year":"2019","journal-title":"Int. J. Oncol."},{"key":"B84","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/ijmm.2024.5374","article-title":"Promising predictive molecular biomarkers for cervical cancer","volume":"53","author":"Lizano","year":"2024","journal-title":"Int. J. Mol. Med."},{"key":"B85","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/978-3-319-95228-4_26","article-title":"Role of JAK-STAT pathway in cancer signaling. Predictive biomarkers in oncology: applications in precision","author":"Luo","year":"2019","journal-title":"Medicine"},{"key":"B86","doi-asserted-by":"publisher","first-page":"115283","DOI":"10.1016\/j.bmc.2019.115283","article-title":"miR-140-3p impedes the proliferation of human cervical cancer cells by targeting RRM2 to induce cell-cycle arrest and early apoptosis","volume":"28","author":"Ma","year":"2020","journal-title":"Bioorg. and Med. Chem."},{"key":"B87","doi-asserted-by":"publisher","first-page":"537","DOI":"10.2174\/138920210793175895","article-title":"MicroRNA: biogenesis, function and role in cancer","volume":"11","author":"MacFarlane","year":"2010","journal-title":"Curr. genomics."},{"key":"B88","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.arcmed.2014.10.008","article-title":"The role of signaling pathways in cervical cancer and molecular therapeutic targets","volume":"45","author":"Manzo-Merino","year":"2014","journal-title":"Archives Med. Res."},{"key":"B89","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.3390\/cancers13051168","article-title":"The role of microRNAs in the cisplatin-and radio-resistance of cervical cancer","volume":"13","author":"Masadah","year":"2021","journal-title":"Cancers"},{"key":"B90","doi-asserted-by":"publisher","first-page":"2485","DOI":"10.4161\/cc.7.16.6453","article-title":"microRNAs and cancer: an overview","volume":"7","author":"Medina","year":"2008","journal-title":"Cell cycle"},{"key":"B91","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1016\/j.febslet.2010.08.009","article-title":"Dysregulation of microRNAs in cancer: playing with fire","volume":"585","author":"Melo","year":"2011","journal-title":"FEBS Lett."},{"key":"B92","doi-asserted-by":"publisher","first-page":"11502","DOI":"10.3390\/ijms231911502","article-title":"miRNA: a promising therapeutic target in cancer","volume":"23","author":"Menon","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"B93","doi-asserted-by":"publisher","first-page":"108480","DOI":"10.1016\/j.abb.2020.108480","article-title":"The roles of microRNA in human cervical cancer","volume":"690","author":"Miao","year":"2020","journal-title":"Archives Biochem. biophysics"},{"key":"B94","doi-asserted-by":"publisher","first-page":"4363","DOI":"10.1007\/s11010-021-04249-4","article-title":"Cervical cancer development, chemoresistance, and therapy: a snapshot of involvement of microRNA","volume":"476","author":"Mitra","year":"2021","journal-title":"Mol. Cell. Biochem."},{"key":"B95","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s12964-023-01117-0","article-title":"A state-of-the-art review on the MicroRNAs roles in hematopoietic stem cell aging and longevity","volume":"21","author":"Ortiz","year":"2023","journal-title":"Cell Commun. Signal."},{"key":"B96","doi-asserted-by":"publisher","first-page":"3455","DOI":"10.3390\/cancers12113455","article-title":"Extracellular MicroRNAs as intercellular mediators and noninvasive biomarkers of cancer","volume":"12","author":"Ortiz-Quintero","year":"2020","journal-title":"Cancers"},{"key":"B97","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.meegid.2018.03.003","article-title":"Understanding the HPV integration and its progression to cervical cancer","volume":"61","author":"Oyervides-Mu\u00f1oz","year":"2018","journal-title":"Infect. Genet. Evol."},{"key":"B98","doi-asserted-by":"publisher","first-page":"3116","DOI":"10.3389\/fmicb.2019.03116","article-title":"Human papillomavirus E6 and E7: the cervical cancer hallmarks and targets for therapy","volume":"10","author":"Pal","year":"2020","journal-title":"Front. Microbiol."},{"key":"B99","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/b978-0-323-99661-7.00003-5","article-title":"Paradigms in miRNA biogenesis pathways","volume":"1","author":"Panda","year":"2024","journal-title":"InMicroRNA Hum. Infect. Dis."},{"key":"B100","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1186\/s12885-018-4590-4","article-title":"MicroRNAs as markers of progression in cervical cancer: a systematic review","volume":"18","author":"Pardini","year":"2018","journal-title":"BMC cancer"},{"key":"B101","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.3892\/or.2018.6219","article-title":"MicroRNA-125 modulates radioresistance through targeting p21 in cervical cancer","volume":"39","author":"Pedroza-Torres","year":"2018","journal-title":"Oncol. Rep."},{"key":"B102","doi-asserted-by":"publisher","first-page":"15004","DOI":"10.1038\/sigtrans.2015.4","article-title":"The role of MicroRNAs in human cancer","volume":"1","author":"Peng","year":"2016","journal-title":"Signal Transduct. Target. Ther."},{"key":"B103","doi-asserted-by":"publisher","first-page":"14089","DOI":"10.18632\/oncotarget.12923","article-title":"The crosstalk between microRNAs and the Wnt\/\u03b2-catenin signaling pathway in cancer","volume":"8","author":"Peng","year":"2017","journal-title":"Oncotarget"},{"key":"B104","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1186\/s12885-016-2231-3","article-title":"Relevance of miR-21 in regulation of tumor suppressor gene PTEN in human cervical cancer cells","volume":"16","author":"Peralta-Zaragoza","year":"2016","journal-title":"BMC cancer"},{"key":"B105","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1177\/1933719112459220","article-title":"Alterations of microRNA expression patterns in human cervical carcinoma cells (Ca Ski) toward 1\u2032 S-1\u2032-acetoxychavicol acetate and cisplatin","volume":"20","author":"Phuah","year":"2013","journal-title":"Reprod. Sci."},{"key":"B106","doi-asserted-by":"publisher","first-page":"4067","DOI":"10.1038\/onc.2011.561","article-title":"MicroRNA-133b is a key promoter of cervical carcinoma development through the activation of the ERK and AKT1 pathways","volume":"31","author":"Qin","year":"2012","journal-title":"Oncogene"},{"key":"B107","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1002\/bit.28029","article-title":"Biogenesis and mechanisms of microRNA\u2010mediated gene regulation","volume":"119","author":"Rani","year":"2022","journal-title":"Biotechnol. Bioeng."},{"key":"B108","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.yexmp.2015.03.006","article-title":"Deregulation of DNMT1, DNMT3B and miR-29s in Burkitt lymphoma suggests novel contribution for disease pathogenesis","volume":"98","author":"Robaina","year":"2015","journal-title":"Exp. Mol. pathology"},{"key":"B109","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1038\/s41569-022-00680-2","article-title":"Non-canonical features of microRNAs: paradigms emerging from cardiovascular disease","volume":"19","author":"Santovito","year":"2022","journal-title":"Nat. Rev. Cardiol."},{"key":"B110","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1309\/AJCPTGD94EVRSJCG","article-title":"American cancer society, American society for colposcopy and cervical pathology, and American society for clinical pathology screening guidelines for the prevention and early detection of cervical cancer","volume":"137","author":"Saslow","year":"2012","journal-title":"Am. J. Clin. pathology"},{"key":"B111","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3892\/ol.2017.7292","article-title":"Modulation of DNA methylation by human papillomavirus E6 and E7 oncoproteins in cervical cancer","volume":"15","author":"Sen","year":"2018","journal-title":"Oncol. Lett."},{"key":"B112","doi-asserted-by":"publisher","first-page":"435","DOI":"10.34172\/apb.2023.047","article-title":"MicroRNAs as targets for cancer diagnosis: interests and limitations","volume":"13","author":"Shademan","year":"2023","journal-title":"Adv. Pharm. Bull."},{"key":"B113","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.3390\/ijms19061664","article-title":"Luteoloside inhibits proliferation and promotes intrinsic and extrinsic pathway-mediated apoptosis involving MAPK and mTOR signaling pathways in human cervical cancer cells","volume":"19","author":"Shao","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"B114","doi-asserted-by":"publisher","first-page":"310","DOI":"10.2174\/1389202915666140528003249","article-title":"A comprehensive review of dysregulated miRNAs involved in cervical cancer","volume":"15","author":"Sharma","year":"2014","journal-title":"Curr. genomics."},{"key":"B115","doi-asserted-by":"publisher","first-page":"5798","DOI":"10.21037\/tcr-20-1294","article-title":"MicroRNAs: potential biomarkers for diagnosis and prognosis of different cancers","volume":"9","author":"Sharma","year":"2020","journal-title":"Transl. cancer Res."},{"key":"B116","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.cancergen.2020.09.003","article-title":"Potential role of microRNAs in the treatment and diagnosis of cervical cancer","volume":"248","author":"Shen","year":"2020","journal-title":"Cancer Genet."},{"key":"B117","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/1746-1596-8-69","article-title":"Upregulation of microRNA-224 is associated with aggressive progression and poor prognosis in human cervical cancer","volume":"8","author":"Shen","year":"2013","journal-title":"Diagn. Pathol."},{"key":"B118","doi-asserted-by":"publisher","first-page":"e109299","DOI":"10.1371\/journal.pone.0109299","article-title":"miR-375 mediated acquired chemo-resistance in cervical cancer by facilitating EMT","volume":"9","author":"Shen","year":"2014","journal-title":"PloS one"},{"key":"B119","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/978-3-030-90214-8_8","article-title":"Small noncoding RNA, microRNA in gene regulation","volume-title":"InFundamentals of RNA structure and function","author":"Shirley","year":"2022"},{"key":"B120","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s13148-018-0587-8","article-title":"The role and mechanisms of action of microRNAs in cancer drug resistance","volume":"11","author":"Si","year":"2019","journal-title":"Clin. epigenetics"},{"key":"B121","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1111\/cas.13104","article-title":"miR\u201025\u20103p reverses epithelial\u2010mesenchymal transition via targeting Sema4C in cisplatin\u2010resistance cervical cancer cells","volume":"108","author":"Song","year":"2017","journal-title":"Cancer Sci."},{"key":"B122","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.3892\/ijo.2011.1322","article-title":"MicroRNA-200a suppresses the Wnt\/\u03b2-catenin signaling pathway by interacting with \u03b2-catenin","volume":"40","author":"Su","year":"2012","journal-title":"Int. J. Oncol."},{"key":"B123","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1002\/jcp.28957","article-title":"miR\u20104429 sensitized cervical cancer cells to irradiation by targeting RAD51","volume":"235","author":"Sun","year":"2020","journal-title":"J. Cell. physiology"},{"key":"B124","doi-asserted-by":"publisher","first-page":"926","DOI":"10.2174\/1389203720666190618101441","article-title":"Roles of E6 and E7 human papillomavirus proteins in molecular pathogenesis of cervical cancer","volume":"20","author":"Taghizadeh","year":"2019","journal-title":"Curr. Protein Peptide Sci."},{"key":"B125","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.ygyno.2012.12.043","article-title":"MicroRNA-182 plays an onco-miRNA role in cervical cancer","volume":"129","author":"Tang","year":"2013","journal-title":"Gynecol. Oncol."},{"key":"B126","doi-asserted-by":"publisher","first-page":"5243","DOI":"10.1002\/jcb.26585","article-title":"RETRACTED: microRNA\u2010383 suppresses the PI3K\u2010AKT\u2010MTOR signaling pathway to inhibit development of cervical cancer via down\u2010regulating PARP2","volume":"119","author":"Teng","year":"2018","journal-title":"J. Cell. Biochem."},{"key":"B127","doi-asserted-by":"publisher","first-page":"25556","DOI":"10.1074\/jbc.M111.221564","article-title":"MicroRNA-372 is down-regulated and targets cyclin-dependent kinase 2 (CDK2) and cyclin A1 in human cervical cancer, which may contribute to tumorigenesis","volume":"286","author":"Tian","year":"2011","journal-title":"J. Biol. Chem."},{"key":"B128","doi-asserted-by":"publisher","first-page":"188491","DOI":"10.1016\/j.bbcan.2020.188491","article-title":"Non-coding RNAs and potential therapeutic targeting in cancer","volume":"1875","author":"Toden","year":"2021","journal-title":"Biochimica Biophysica Acta (BBA)-Reviews Cancer"},{"key":"B129","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/s41580-018-0059-1","article-title":"Regulation of microRNA biogenesis and its crosstalk with other cellular pathways","volume":"20","author":"Treiber","year":"2019","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"B130","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.3390\/genes14061141","article-title":"JAK\/STAT signaling and Cervical Cancer: from the cell surface to the Nucleus","volume":"14","author":"Valle-Mendiola","year":"2023","journal-title":"Genes"},{"key":"B131","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/s41586-019-1730-1","article-title":"A view on drug resistance in cancer","volume":"575","author":"Vasan","year":"2019","journal-title":"Nature"},{"key":"B132","doi-asserted-by":"publisher","first-page":"634","DOI":"10.2174\/138161213804581837","article-title":"Wnt\/beta-catenin signaling and small molecule inhibitors","volume":"19","author":"Voronkov","year":"2013","journal-title":"Curr. Pharm. Des."},{"key":"B133","volume-title":"The roles and clinical significance of microRNAs in cervical cancer","author":"Wang","year":"2016"},{"key":"B134","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/j.febslet.2013.01.016","article-title":"MiR-214 reduces cell survival and enhances cisplatin-induced cytotoxicity via down-regulation of Bcl2l2 in cervical cancer cells","volume":"587","author":"Wang","year":"2013","journal-title":"FEBS Lett."},{"key":"B135","doi-asserted-by":"publisher","first-page":"BSR20181377","DOI":"10.1042\/BSR20181377","article-title":"The role of miRNAs in the invasion and metastasis of cervical cancer","volume":"39","author":"Wang","year":"2019","journal-title":"Biosci. Rep."},{"key":"B136","doi-asserted-by":"publisher","first-page":"3703","DOI":"10.1007\/s13277-014-3009-3","article-title":"Downregulation of microRNA-145 is associated with aggressive progression and poor prognosis in human cervical cancer","volume":"36","author":"Wang","year":"2015","journal-title":"Tumor Biol."},{"key":"B137","doi-asserted-by":"publisher","first-page":"977","DOI":"10.3727\/096504017X15037506066252","article-title":"[ARTICLE WITHDRAWN] overexpression of MicroRNA-34a-5p inhibits proliferation and promotes apoptosis of human cervical cancer cells by downregulation of bcl-2","volume":"26","author":"Wang","year":"","journal-title":"Oncol. Res."},{"key":"B138","doi-asserted-by":"publisher","first-page":"141","DOI":"10.20517\/cdr.2019.10","article-title":"Drug resistance and combating drug resistance in cancer","volume":"2","author":"Wang","year":"2019","journal-title":"Cancer drug Resist."},{"key":"B139","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2022\/1123839","article-title":"FAM201A promotes cervical cancer progression and metastasis through miR-1271-5p\/Flotillin-1 axis targeting-induced Wnt\/\u03b2-catenin pathway","volume":"2022","author":"Wang","year":"2022","journal-title":"J. Oncol."},{"key":"B140","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1080\/15384047.2018.1491497","article-title":"Upregulation of microRNA-129-5p inhibits cell invasion, migration and tumor angiogenesis by inhibiting ZIC2 via downregulation of the Hedgehog signaling pathway in cervical cancer","volume":"19","author":"Wang","year":"","journal-title":"Cancer Biol. and Ther."},{"key":"B141","doi-asserted-by":"publisher","first-page":"15593258211001255","DOI":"10.1177\/15593258211001255","article-title":"MiRNA-873-5p acts as a potential novel biomarker and promotes cervical cancer progression by regulating ZEB1 via notch signaling pathway","volume":"19","author":"Wen","year":"2021","journal-title":"Dose-Response"},{"key":"B142","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s10456-019-09665-1","article-title":"Cancer-derived exosomal miR-221-3p promotes angiogenesis by targeting THBS2 in cervical squamous cell carcinoma","volume":"22","author":"Wu","year":"2019","journal-title":"Angiogenesis"},{"key":"B143","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1016\/j.biopha.2018.06.033","article-title":"Over-expression of miR-15a-3p enhances the radiosensitivity of cervical cancer by targeting tumor protein D52","volume":"105","author":"Wu","year":"2018","journal-title":"Biomed. and Pharmacother."},{"key":"B144","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.ccr.2008.10.005","article-title":"miR-296 regulates growth factor receptor overexpression in angiogenic endothelial cells","volume":"14","author":"W\u00fcrdinger","year":"2008","journal-title":"Cancer Cell"},{"key":"B145","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s13046-017-0520-6","article-title":"iASPP induces EMT and cisplatin resistance in human cervical cancer through miR-20a-FBXL5\/BTG3 signaling","volume":"36","author":"Xiong","year":"2017","journal-title":"J. Exp. and Clin. Cancer Res."},{"key":"B146","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1007\/s13105-016-0511-7","article-title":"Inhibition of microRNA-181a may suppress proliferation and invasion and promote apoptosis of cervical cancer cells through the PTEN\/Akt\/FOXO1 pathway","volume":"72","author":"Xu","year":"2016","journal-title":"J. physiology Biochem."},{"key":"B147","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s41065-019-0087-7","article-title":"The inhibition of miR-126 in cell migration and invasion of cervical cancer through regulating ZEB1","volume":"156","author":"Xu","year":"2019","journal-title":"Hereditas"},{"key":"B148","doi-asserted-by":"publisher","first-page":"647","DOI":"10.2174\/1874467214666210914122010","article-title":"The role of miR-129-5p in cancer: a novel therapeutic target","volume":"15","author":"Xu","year":"2022","journal-title":"Curr. Mol. Pharmacol."},{"key":"B149","doi-asserted-by":"publisher","first-page":"1170059","DOI":"10.3389\/fcell.2023.1170059","article-title":"The mechanisms and diagnostic potential of lncRNAs, miRNAs, and their related signaling pathways in cervical cancer","volume":"11","author":"Xu","year":"2023","journal-title":"Front. Cell Dev. Biol."},{"key":"B151","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.3892\/ijo.2013.1851","article-title":"Tumor suppressive microRNA-218 inhibits cancer cell migration and invasion by targeting focal adhesion pathways in cervical squamous cell carcinoma","volume":"42","author":"Yamamoto","year":"2013","journal-title":"Int. J. Oncol."},{"key":"B152","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1016\/j.molcel.2011.07.024","article-title":"Alternative miRNA biogenesis pathways and the interpretation of core miRNA pathway mutants","volume":"43","author":"Yang","year":"2011","journal-title":"Mol. Cell"},{"key":"B153","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.7150\/jca.22005","article-title":"Wnt signaling in cervical cancer?","volume":"9","author":"Yang","year":"2018","journal-title":"J. Cancer"},{"key":"B154","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s10528-021-10098-z","article-title":"miR-122 inhibits the cervical cancer development by targeting the oncogene RAD21","volume":"60","author":"Yang","year":"2022","journal-title":"Biochem. Genet."},{"key":"B155","doi-asserted-by":"publisher","first-page":"11602","DOI":"10.1002\/cam4.5826","article-title":"Anti\u2010tumor effects of miR\u201034a by regulating immune cells in the tumor microenvironment","volume":"12","author":"Yin","year":"2023","journal-title":"Cancer Med."},{"key":"B156","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.semcancer.2021.06.019","article-title":"Attacking the PI3K\/Akt\/mTOR signaling pathway for targeted therapeutic treatment in human cancer","volume":"85","author":"Yu","year":"2022","journal-title":"InSeminars cancer Biol."},{"key":"B157","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1134\/s106816202001015x","article-title":"The fundamentals of miRNA biology: structure, biogenesis, and regulatory functions","volume":"46","author":"Zaporozhchenko","year":"2020","journal-title":"Russ. J. Bioorg. Chem."},{"key":"B158","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.biopha.2016.02.033","article-title":"MiR-200b promotes the cell proliferation and metastasis of cervical cancer by inhibiting FOXG1","volume":"79","author":"Zeng","year":"2016","journal-title":"Biomed. and Pharmacother."},{"key":"B159","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1007\/s00404-015-3702-5","article-title":"Dysregulated microRNAs involved in the progression of cervical neoplasm","volume":"292","author":"Zeng","year":"2015","journal-title":"Archives Gynecol. obstetrics"},{"key":"B160","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/1475-2867-13-118","article-title":"A specific miRNA signature promotes radioresistance of human cervical cancer cells","volume":"13","author":"Zhang","year":"2013","journal-title":"Cancer Cell Int."},{"key":"B161","doi-asserted-by":"publisher","first-page":"18626","DOI":"10.1002\/jcp.28501","article-title":"Downregulation of microRNA\u2010205 inhibits cell invasion and angiogenesis of cervical cancer through TSLC1\u2010mediated Akt signaling pathway","volume":"234","author":"Zhang","year":"","journal-title":"J. Cell. physiology"},{"key":"B162","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1002\/jcb.26259","article-title":"MicroRNA\u2010137 is negatively associated with clinical outcome and regulates tumor development through EZH2 in cervical cancer","volume":"119","author":"Zhang","year":"2018","journal-title":"J. Cell. Biochem."},{"key":"B163","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.21037\/atm-20-6830","article-title":"miR-326 inhibits the cell proliferation and cancer stem cell-like property of cervical cancer in vitro and oncogenesis in vivo via targeting TCF4","volume":"8","author":"Zhang","year":"2020","journal-title":"Ann. Transl. Med."},{"key":"B164","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1002\/mc.22317","article-title":"Down\u2010regulation of microRNA\u20109 leads to activation of IL\u20106\/Jak\/STAT3 pathway through directly targeting IL\u20106 in HeLa cell","volume":"55","author":"Zhang","year":"2016","journal-title":"Mol. Carcinog."},{"key":"B165","doi-asserted-by":"publisher","first-page":"10307","DOI":"10.2147\/CMAR.S221527","article-title":"Cervical cancer cells-secreted exosomal microRNA-221-3p promotes invasion, migration and angiogenesis of microvascular endothelial cells in cervical cancer by down-regulating MAPK10 expression","volume":"9","author":"Zhang","year":"","journal-title":"Cancer Manag. Res."},{"key":"B166","doi-asserted-by":"publisher","first-page":"BSR20181815","DOI":"10.1042\/BSR20181815","article-title":"Up-regulation of miRNA-148a inhibits proliferation, invasion, and migration while promoting apoptosis of cervical cancer cells by down-regulating RRS1","volume":"39","author":"Zhang","year":"","journal-title":"Biosci. Rep."},{"key":"B167","doi-asserted-by":"publisher","first-page":"116182","DOI":"10.1016\/j.biopha.2024.116182","article-title":"Interactions between miRNAs and the Wnt\/\u03b2-catenin signaling pathway in endometriosis","volume":"171","author":"Zhang","year":"2024","journal-title":"Biomed. and Pharmacother."},{"key":"B168","doi-asserted-by":"publisher","first-page":"e0120905","DOI":"10.1371\/journal.pone.0120905","article-title":"MiR-20a promotes cervical cancer proliferation and metastasis in vitro and in vivo","volume":"10","author":"Zhao","year":"2015","journal-title":"PloS one"},{"key":"B169","doi-asserted-by":"publisher","first-page":"5580","DOI":"10.26355\/eurrev_201712_13997","article-title":"MicroRNA-143 regulates the proliferation and apoptosis of cervical cancer cells by targeting HIF-1\u03b1","volume":"21","author":"Zhao","year":"2017","journal-title":"Eur. Rev. Med. and Pharmacol. Sci."},{"key":"B170","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1159\/000520980","article-title":"Identification of miR-885-5p as a tumor biomarker: regulation of cellular function in cervical cancer","volume":"86","author":"Zu","year":"2022","journal-title":"Gynecol. Obstetric Investigation"}],"container-title":["Frontiers in Cell and Developmental Biology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2024.1397945\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,28]],"date-time":"2024-08-28T04:34:07Z","timestamp":1724819647000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2024.1397945\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,28]]},"references-count":170,"alternative-id":["10.3389\/fcell.2024.1397945"],"URL":"https:\/\/doi.org\/10.3389\/fcell.2024.1397945","relation":{},"ISSN":["2296-634X"],"issn-type":[{"value":"2296-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,28]]},"article-number":"1397945"}}